Abiomed

American medical device company specializing in heart pumps

Abiomed is an American medical device company that develops and manufactures heart pumps. The company is headquartered in Danvers, Massachusetts.

History

Abiomed was founded in 1981 by Dr. David M. Lederman. The company initially focused on developing an artificial heart, but later shifted its focus to ventricular assist devices (VADs) and other heart pump technologies. In 2001, Abiomed received FDA approval for its first heart pump, the Impella 2.5, which is used to support patients with severe coronary artery disease.

Products

Abiomed's primary product line is the Impella series of heart pumps. These devices are designed to provide temporary support to the heart's ventricular function, allowing the heart to rest and recover. The Impella pumps are inserted percutaneously and can be used in various clinical settings, including during percutaneous coronary intervention (PCI) and in patients with cardiogenic shock.

Impella Series

• Impella 2.5: The first FDA-approved heart pump from Abiomed, used for high-risk PCI procedures.
• Impella CP: Provides greater flow than the Impella 2.5 and is used for patients with more severe heart conditions.
• Impella 5.0 and 5.5: Designed for patients requiring full cardiac support, these pumps can deliver higher flow rates.
• Impella RP: Specifically designed to support the right side of the heart in cases of right heart failure.

Technology

Abiomed's heart pumps utilize a minimally invasive approach to provide mechanical circulatory support. The Impella devices are inserted through the femoral artery or other access points and positioned in the heart to assist with blood flow. The pumps are powered by an external console that allows for precise control of the device's operation.

Research and Development

Abiomed invests heavily in research and development to advance its heart pump technologies. The company collaborates with leading cardiologists and cardiothoracic surgeons to improve patient outcomes and expand the indications for its devices. Abiomed is also involved in clinical trials to evaluate the safety and efficacy of its products in various patient populations.

Corporate Structure

Abiomed is a publicly traded company listed on the NASDAQ under the ticker symbol ABMD. The company has a global presence, with offices and facilities in the United States, Europe, and Asia. Abiomed's leadership team is composed of experienced professionals in the medical device industry.

Related pages

• Heart pump
• Ventricular assist device
• Cardiogenic shock
• Percutaneous coronary intervention

Gallery

• 
  Abiomed logo